Program was developed by Novartis, a science and technology company created in 1996 through a merger of Ciba-Geigy and Sandoz. Nevertheless, Novartis and its predecessor companies trace back to more than 250 years, with a rich history of developing innovative products.
Program is an ectoparasiticide used in the prevention and lasting control of flea infestations and treatment of flea allergic dermatitis in dogs and cats. Program comes in tablets for dogs and cats, making it a systemic monthly antiparasitic treatment.
Briefly, Program’s function is to inhibit the growth of fleas by infeasibility of their eggs. As such, this product breaks the life cycle of fleas, preventing their multiplication. The main active ingredient in Program tablets is lufenuron, which will be stored in your pet’s body fat and transferred to adult fleas through your pet’s blood when they feed. Adult fleas transfer it to their growing eggs through their blood, thus breaking their life cycle.
So, if you want to get to the root of your pet’s flea problem, you need Program!